Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer.

Ntavatzikos A, Spathis A, Patapis P, Machairas N, Peros G, Konstantoudakis S, Leventakou D, Panayiotides IG, Karakitsos P, Koumarianou A.

World J Gastroenterol. 2017 Aug 28;23(32):5913-5924. doi: 10.3748/wjg.v23.i32.5913.

2.

A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma.

Palumbo T, Poultsides GA, Kouraklis G, Liakakos T, Drakaki A, Peros G, Hatziapostolou M, Iliopoulos D.

BMC Cancer. 2016 Jun 3;16:353. doi: 10.1186/s12885-016-2384-0.

3.

Cascaded learning vector quantizer neural networks for the discrimination of thyroid lesions.

Varlatzidou A, Pouliakis A, Stamataki M, Meristoudis C, Margari N, Peros G, Panayiotides JG, Karakitsos P.

Anal Quant Cytol Histol. 2011 Dec;33(6):323-34.

PMID:
22590810
4.

Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis.

Schildberg CW, Croner R, Merkel S, Schellerer V, Müller V, Yedibela S, Hohenberger W, Peros G, Perrakis A.

World J Surg. 2012 Apr;36(4):872-8. doi: 10.1007/s00268-012-1492-5.

PMID:
22354489
5.

Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.

Tsapralis D, Panayiotides I, Peros G, Liakakos T, Karamitopoulou E.

World J Gastroenterol. 2012 Jan 14;18(2):150-5. doi: 10.3748/wjg.v18.i2.150.

6.

Cell cycle analysis of colorectal brushings collected in liquid-based cytology.

Spathis A, Kottaridi C, Georgoulakis J, Foukas P, Panayiotides I, Peros G, Karakitsos P.

Anal Quant Cytol Histol. 2011 Feb;33(1):29-35.

PMID:
22125844
7.

Necrosis and angioinvasion predict adverse outcome in pancreatic neuroendocrine tumors after curative surgical resection: results of a single-center series.

Demir R, Pohl J, Agaimy A, Peros G, Perrakis A, Merkel S, Hohenberger W, Klein P.

World J Surg. 2011 Dec;35(12):2764-72. doi: 10.1007/s00268-011-1262-9.

PMID:
21927963
8.

Management of ovarian carcinoid syndrome.

Pappa I, Peros G, Lappas C, Vassiliu P, Arkadopoulos N, Smyrniotis V.

Int J Gynaecol Obstet. 2011 Nov;115(2):205-7. doi: 10.1016/j.ijgo.2011.06.017. Epub 2011 Aug 26. No abstract available.

PMID:
21872235
9.

Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I.

Hum Pathol. 2011 Dec;42(12):1833-40. doi: 10.1016/j.humpath.2011.02.010. Epub 2011 Jun 12.

PMID:
21664647
10.

Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.

Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM, Lugli A.

Hum Pathol. 2011 Dec;42(12):1888-96. doi: 10.1016/j.humpath.2010.06.020. Epub 2011 Jun 12.

PMID:
21664646
11.

Risk factors for colorectal polyps: findings from a Greek case-control study.

Karagianni V, Merikas E, Georgopoulos F, Gikas A, Athanasopoulos N, Malgarinos G, Peros G, Triantafillidis JK.

Rev Med Chir Soc Med Nat Iasi. 2010 Jul-Sep;114(3):662-70.

PMID:
21235114
12.

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.

Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A.

Pathology. 2011 Feb;43(2):133-7. doi: 10.1097/PAT.0b013e3283425b7f.

PMID:
21233674
13.

Definition of the "Drug-Angiogenic-Activity-Index" that allows the quantification of the positive and negative angiogenic active drugs: a study based on the chorioallantoic membrane model.

Demir R, Peros G, Hohenberger W.

Pathol Oncol Res. 2011 Jun;17(2):309-13. doi: 10.1007/s12253-010-9318-y. Epub 2011 Jan 8.

PMID:
21221880
14.

Guillain-Barrē syndrome following total gastrectomy/esophagectomy: A very rare and dramatic post-operative complication with a favourable outcome.

Papantoni E, Sakorafas GH, Zouros E, Peros G.

ANZ J Surg. 2010 Nov;80(11):858. doi: 10.1111/j.1445-2197.2010.05516.x. No abstract available.

PMID:
20969704
15.

Study on the reproducibility of thyroid lesions telecytology diagnoses based upon digitized images.

Georgoulakis J, Archondakis S, Panayiotides I, Anninos D, Skagias L, Stamataki M, Peros G, Karakitsos P.

Diagn Cytopathol. 2011 Jul;39(7):495-9. doi: 10.1002/dc.21419. Epub 2010 Aug 20.

PMID:
20730904
16.

Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.

Karamitopoulou E, Lugli A, Panayiotides I, Karakitsos P, Peros G, Rallis G, Patsouris ES, Terracciano L, Zlobec I.

Histopathology. 2010 Aug;57(2):233-43. doi: 10.1111/j.1365-2559.2010.03615.x.

PMID:
20716165
17.

Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.

Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, Zuber M, Droeser R, Muraro MG, Mengus C, Oertli D, Ferrone S, Terracciano L, Spagnoli GC.

Int J Cancer. 2011 Jun 1;128(11):2663-72. doi: 10.1002/ijc.25609. Epub 2010 Oct 13.

18.

Simultaneous occurrence of Warthin-like papillary carcinoma and lymphoma of the mucosa associated lymphoid tissue in Hashimoto thyroiditis.

Panayiotides IG, Foukas PG, Meristoudis C, Zourla AP, Peros G, Karakitsos P.

J Clin Pathol. 2010 Jul;63(7):662-3. doi: 10.1136/jcp.2010.076299. No abstract available.

PMID:
20591920
19.
20.

Role of tumor size in the pre-operative management of rectal cancer patients.

Zlobec I, Minoo P, Karamitopoulou E, Peros G, Patsouris ES, Lehmann F, Lugli A.

BMC Gastroenterol. 2010 Jun 15;10:61. doi: 10.1186/1471-230X-10-61.

Supplemental Content

Support Center